StevenRosenMD

PubMed

• Function and mechanism of bispecific antibodies targeting SARS-CoV-2.
  Li, Z., Zhang, Z., Feng, M., Rosen, S.> ;Cell Insight. 2024 Apr 1
• Congressional Investigation of RevAssist-Linked and General Pricing Strategies for Lenalidomide.
  Charles L Bennett, Jason B Gibbons, Antonio Trujillo, Kenneth R Carson, Kevin Knopf, Chadi Nabhan, Steven T Rosen, David M Aboulafia> ;JCO Oncology Practice. 2024 Feb 27
• Therapeutic targeting Tudor domains in leukemia via CRISPR-Scan Assisted Drug Discovery.
  Chan, A., Han, L., Delaney, C., Wang, X., Mukhaleva, E., Li, M., Yang, L., Pokharel, S., Mattson, N., Garcia, M., Wang, B., Xu, X., Zhang, L., Singh, P., Elsayed, Z., ...> ;Science Advances. 2024 Feb 23
• A novel class of inhibitors that disrupts the stability of integrin heterodimers identified by CRISPR-tiling-instructed genetic screens.
  Nicole M Mattson, Anthony K N Chan, Kazuya Miyashita, Elizaveta Mukhaleva, Wen-Han Chang, Lu Yang, Ning Ma, Yingyu Wang, Sheela Pangeni Pokharel, Mingli Li, Qiao Liu, ...> ;Nature Structural & Molecular Biology. 2024 Mar 1
• METTL16 promotes liver cancer stem cell self-renewal via controlling ribosome biogenesis and mRNA translation.
  Meilin Xue, Lei Dong, Honghai Zhang, Yangchan Li, Kangqiang Qiu, Zhicong Zhao, Min Gao, Li Han, Anthony K N Chan, Wei Li, Keith Leung, Kitty Wang, Sheela Pangeni Pokha...> ;Journal of Hematology & Oncology. 2024 Feb 1
• DEDD Motif Mutation Confers Hypermutation in Endometrial Cancer and Durable Response to Pembrolizumab.
  Christina Hsiao Wei, Edward Wenge Wang, Lingzi Ma, Yajing Zhou, Li Zheng, Heather Hampel, Susan Shehayeb, Stephen Lee, Joshua Cohen, Adrian Kohut, Fang Fan, Steven Ros...> ;Cancers. 2023 Nov 30
• 1 citations
  A phase 1 trial of 8-chloro-adenosine in relapsed/refractory acute myeloid leukemia: An evaluation of safety and pharmacokinetics.
  Vinod Pullarkat, Lisa S Chen, Joycelynne Palmer, Jianying Zhang, Timothy W Synold, Ralf Buettner, Le Xuan Truong Nguyen, Guido Marcucci, Ni-Chun Tsai, Yan Wang, James ...> ;Cancer. 2024 Mar 1
• 7 citations
  Pembrolizumab plus vorinostat induces responses in patients with Hodgkin lymphoma refractory to prior PD-1 blockade.
  Matthew Mei, Lu Chen, James Godfrey, Joo Song, Colt Egelston, Sandrine Puverel, L Elizabeth Budde, Saro Armenian, Liana Nikolaenko, Mary Nwangwu, Weihua Guo, Lei Gao, ...> ;Blood. 2023 Oct 19
• 4 citations
  TET2-mediated mRNA demethylation regulates leukemia stem cell homing and self-renewal.
  Yangchan Li, Meilin Xue, Xiaolan Deng, Lei Dong, Le Xuan Truong Nguyen, Lili Ren, Li Han, Chenying Li, Jianhuang Xue, Zhicong Zhao, Wei Li, Ying Qing, Chao Shen, Brand...> ;Cell Stem Cell. 2023 Aug 3
• Results from a phase I trial of pembrolizumab plus vorinostat in relapsed/refractory B-cell non-Hodgkin lymphoma.
  James Godfrey, Matthew Mei, Lu Chen, Joo Y Song, Victoria Bedell, Elizabeth Budde, Saro Armenian, Sandrine Puverel, Liana Nikolaenko, Robert Chen, Shari Daniels, Neena...> ;Haematologica. 2024 Feb 1
• 4 citations
  P38 kinase in gastrointestinal cancers.
  Thuy Phan, Xu Hannah Zhang, Steven Rosen, Laleh G Melstrom> ;Cancer Gene Therapy. 2023 Sep 1
• 2 citations
  Intrinsic suppression of type I interferon production underlies the therapeutic efficacy of IL-15-producing natural killer cells in B-cell acute lymphoblastic leukemia.
  Anil Kumar, Adeleh Taghi Khani, Caroline Duault, Soraya Aramburo, Ashly Sanchez Ortiz, Sung June Lee, Anthony Chan, Tinisha McDonald, Min Huang, Norman J Lacayo, Kathl...> ;Journal for Immunotherapy of Cancer. 2023 May 1
• 7 citations
  Epigenetic Control of Translation Checkpoint and Tumor Progression via RUVBL1-EEF1A1 Axis.
  Mingli Li, Lu Yang, Anthony K N Chan, Sheela Pangeni Pokharel, Qiao Liu, Nicole Mattson, Xiaobao Xu, Wen-Han Chang, Kazuya Miyashita, Priyanka Singh, Leisi Zhang, Magg...> ;Advanced Science. 2023 Jun 1
• 3 citations
  METTL3-Mediated m6A Modification Controls Splicing Factor Abundance and Contributes to Aggressive CLL.
  Yiming Wu, Meiling Jin, Mike Fernandez, Kevyn L Hart, Aijun Liao, Xinzhou Ge, Stacey M Fernandes, Tinisha McDonald, Zhenhua Chen, Daniel Röth, Lucy Y Ghoda, Guido Marc...> ;Blood Cancer Discovery. 2023 May 1
• 2 citations
  Blockade of the Immune Checkpoint CD47 by TTI-621 Potentiates the Response to Anti-PD-L1 in Cutaneous T-Cell Lymphoma.
  Zhen Han, Xiwei Wu, Hanjun Qin, Yate-Ching Yuan, Jasmine Zain, D Lynne Smith, Oleg E Akilov, Steven T Rosen, Mingye Feng, Christiane Querfeld> ;The Journal of Investigative Dermatology. 2023 Aug 1
• 4 citations
  Mechanism of SUMOylation-Mediated Regulation of Type I IFN Expression.
  Li Du, Wei Liu, Steven T Rosen, Yuan Chen> ;Journal of Molecular Biology. 2023 Mar 1
• Leflunomide Confers Rapid Recovery from COVID-19 and is Coupled with Temporal Immunologic Changes.
  Ada Alice Dona, James F Sanchez, Joycelynne M Palmer, Timothy W Synold, Flavia Chiuppesi, Sandra Thomas, Enrico Caserta, Mahmoud Singer, Theophilus Tandoh, Arnab Chowd...> ;Journal of Immunological Sciences. 2023 Jan 1
• 13 citations
  Brentuximab vedotin plus nivolumab after autologous haematopoietic stem-cell transplantation for adult patients with high-risk classic Hodgkin lymphoma: a multicentre,...
  Alex F Herrera, Lu Chen, Yago Nieto, Leona Holmberg, Patrick Johnston, Matthew Mei, Leslie Popplewell, Saro Armenian, Thai Cao, Leonardo Farol, Firoozeh Sahebi, Ricard...> ;The Lancet. Haematology. 2023 Jan 1
• 6 citations
  ACTR5 controls CDKN2A and tumor progression in an INO80-independent manner.
  Xiaobao Xu, Anthony K N Chan, Mingli Li, Qiao Liu, Nicole Mattson, Sheela Pangeni Pokharel, Wen-Han Chang, Yate-Ching Yuan, Jinhui Wang, Roger E Moore, Patrick Pirrott...> ;Science Advances. 2022 Dec 23
• 12 citations
  Cost-effectiveness of polatuzumab vedotin combined with chemoimmunotherapy in untreated diffuse large B-cell lymphoma.
  Swetha Kambhampati, Monica Saumoy, Yecheskel Schneider, Stacy Pak, Lihua Elizabeth Budde, Matthew G Mei, Tanya Siddiqi, Leslie L Popplewell, Yi-Ping Wen, Jasmine Zain,...> ;Blood. 2022 Dec 22
• 15 citations
  Cost-effectiveness of second-line axicabtagene ciloleucel in relapsed refractory diffuse large B-cell lymphoma.
  Swetha Kambhampati, Monica Saumoy, Yecheskel Schneider, Steve Serrao, Pejman Solaimani, Lihua Elizabeth Budde, Matthew G Mei, Leslie L Popplewell, Tanya Siddiqi, Jasmi...> ;Blood. 2022 Nov 10
• 1 citations
  Increasing clinician participation in tobacco cessation by an implementation science-based tobacco cessation champion program.
  Cary A Presant, Kimlin Ashing, Sophia Yeung, Jonjon Macalintal, Brian Tiep, Argelia Sandoval, Susan Brown, Mary Cianfrocca, Loretta Erhunmwunsee, Dan Raz, Arya Amini, ...> ;Cancer Causes & Control. 2023 Jan 1
• 425 citations
  The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee.
  Elias Campo, Elaine S Jaffe, James R Cook, Leticia Quintanilla-Martinez, Steven H Swerdlow, Kenneth C Anderson, Pierre Brousset, Lorenzo Cerroni, Laurence de Leval, St...> ;Blood. 2022 Sep 15
• Dual targeting fixed duration frontline monoclonal antibody therapy for chronic lymphocytic leukemia: A phase 2 study.
  Shuo Ma, Steven T Rosen, Maria Winqvist, Olga Frankfurt, Jane N Winter, Leo Gordon, Irene Helenowski, Hui Zhang, Jennifer Kreutzer, Sonja Sönnert-Husa, Anders Österbor...> ;Leukemia Research. 2022 Nov 1
• 9 citations
  Vaccine-induced spike- and nucleocapsid-specific cellular responses maintain potent cross-reactivity to SARS-CoV-2 Delta and Omicron variants.
  Flavia Chiuppesi, John A Zaia, Katelyn Faircloth, Daisy Johnson, Minh Ly, Veronica Karpinski, Corinna La Rosa, Jennifer Drake, Joan Marcia, Ann Marie Acosta, Shannon D...> ;Iscience. 2022 Aug 19
• Join now to see all

Journal Articles

• Chronic Lymphocytic Leukemia A Clinical Review, Clinical Review & Education  
  Nabhan Chadi, Rosen ST, JAMA, 1/3/2014
• Update on the Risk Prediction and Prevention of Anticancer therapy-induced Cardiotoxicity  
  Bhave M, Shah A, Akhter N, Rosen ST, Current Opinions in Oncology, 1/1/2014
• Cardiovascular Toxicity of Biologic Agents for Cancer Therapy  
  Bhave M, Akhter N, Rosen ST, Oncology, 1/1/2014
• High incidence of gastrointestinal tract pathology and nnnautoimmunity in primary cutaneous marginal zone lymphoma  
  Guitart J, Deonizio J, Bloom T, Martinez-Escala ME, Kuzel T, Gerami P, Kwasny M, Rosen ST, JAMA Dermatology, 1/1/2014
• B-Catenin induces T-cell transformation by promoting genomic instability  
  Dose M, Emmanuel AO, Chaumeil J, Zhang J, Sun T, Germar K, Aghajani K, Davis EM, Keerthivasan S, Bredemeyer A, Sleckman BP, Rosen ST, Skok JA, LeBeau MM, Georgopoulos ..., Proc Natl Acad Sci USA, 1/1/2014
• Multiple Successful Desensitizations to Brentuximab Vedotin (SGN-35); A Case Report and Literature Review  
  DeVita M, Evens A, Rosen ST, Greenberger P, Petrich A, Journal of the National Comprehensive Cancer Network, 1/1/2014
• Emerging therapeutic paradigms to target the deregulated JAK/STAT pathways in hematological malignancies  
  Mughal TI, Girnius S, Rosen S, Kumar S, Weistner A, Abdel-Wahab O, Kiladjian J-J, Wilson WH, van Etten RA, Leuk Lymphoma, 1/11/2013
• Cancer Metabolism as a Therapeutic Target  
  Batra S, Adekola KUA, Rosen ST, Shanmugam M, Oncology, 1/1/2013
• Peripheral T-Cell Lymphoma: New Therapeutic Strategies  
  Petrich AM, Rosen ST, Oncology, 1/1/2013
• Clinical Roundtable Monograph: Unmet Needs in the Treatment of Mantle Cell Lymphoma  
  Rosen ST, Link BK, Clinical Advances in Hematology & Oncology, 1/1/2013
• Acute Kidney Injury and Bisphosphonate Use in Cancer: A Report From the Research on Adverse Drug Events and Reports (RADAR) Project  
  Edwards BJ, Usmani S, Raisch DW, McKoy JM, Samaras AT, Belknap SM, Trifilio SM, Harh ABunta AD, Abu-Alfa A, Langman CB, Rosen ST, West DP, J Oncol Pract, 1/1/2013
• Outcomes of Patients Treated with Single-Fraction Dose of Palliative Radiation for Cutaneious T-Cell Lymphomas  
  Thomas TO, Agrawal BA, Guitart J, Rosen ST, Rademaker AW, Querfeld, C, Hayes JP, Kuzel TM and Mittal BB, Int J Radiation Oncol Biol Phys, 1/1/2013
• Combination of the Glucocorticoid Receptor Selective Activator - Compound A with Proteasome Inhibitor as a Novel Strategy for Chemotherapy of Hematological Malignancies  
  Lesovaya E, Yemelyanov A, Kirsanov K, Popa A, Belitsky G, Yakubovskaya M, Gordon L, Rosen ST, Budunova I, Cell Cycle, 1/1/2013
• An epithelial-mesenchymaltransition gene signature predicts resistance to EGFR and PI3K inhibitors and identifies Axl as a therapeutic target for overcoming EGFR inhib...  
  Byers LA, Diao L, Wang J, Saintigny P, Girard L, Peyton M, Shen L, Fan Y, Giri U, Gumula PK, Nilsson MB, Gudikote J, Tran H, Cardnell RJG, Bearss DJ, Warner SL, Foulks..., Clinical Cancer Research, 1/1/2013
• Expression and Phosphorylation of the AS160_v2 Splice Variant supports GLUT4 Activation and the Warburg Effect in Multiple Myeloma  
  Cheng JC, McBrayer SK, Rosen ST, Shanmugam M, Cancer Metabolism, 1/1/2013
• Novel Phenotypic Fluorescent Three-Dimensional Co-Culture Platforms for Recapitulating Tumor in vivo Progression and for Personalized Therapy  
  Fang C, Man Yan-Gao, Cuttitta F, Stetler-Stevenson W, Salomon D, Mazar A, Kulesza P, Rosen S, Avital I, Stojadinovic A, Jewett A, Jiang B, Mulshine J, Journal of Cancer, 1/1/2013
• Final Results of a open-label multicenter phase II trial of lenalidomide monotherapy in refractory T-cell lymphoma  
  Querfeld C, Rosen ST, Guitart J, Duvic M, Kim YH, Dusza SW, Kuzel TM, Blood, 1/1/2013
• A phase I/II trial of Bortezomib combined concurrently with gemcitabine for relapsed or refractory DLBCL and peripheral T-cell lymphomas  
  Evens A, Rosen ST, Helenowski I, Kline J, Larsen A, Colvin J, Winter,J, van Besien K, Gordon L, Smith S, British Journal of Haemotology, 1/1/2013
• Multiple Myeloma exhibits Novel Dependence on GLUT4, GLUT8, and GLUT11: Implications for Glucose Transporter-Directed Therapy  
  McBrayer S, Cheng J, Singhal S, Krett NL, Rosen ST, Shanmugam M, Blood, 1/27/2012
• Cutaneous T-Cell Lymphomas: A Review of New Discoveries and Treatments  
  Bloom T, Kuzel TM, Querfeld C, Guitart J, Rosen ST, Current Treatment Options in Oncology, 1/1/2012
• Pilot neoadjuvant trial in HER2 positive breast cancer with combination of nab-paclitaxel and lapatinib  
  Kaklamani VG, Siziopikou K, Scholtens D, Lacouture M, Gordon J, Uthe R, Meservey C, Hansen N, Khan SA, Jeruss JS, Bethke K, Cianfrocca M, Rosen S, Von Roenn J, Wayne J..., Breast Cancer Res Treat, 1/1/2012
• 8-Amino-Adenosine Activates p53-Independent Cell Death of Metastatic Breast Cancers  
  Polotskaia A, Hoffman S, Gamss S, Krett NL, Shanmugam M, Rosen ST, and Bargonetti J, Molecular Cancer Therapeutic, 1/1/2012
• Cutaneous Gamm-delta T-Cell Lymphomas: a Spectrum of Presentations with Overlap with Other Cytotoxic Lymphomas  
  Guitart J,Youn K, Selim A,Weisenburger D, Kim E, Wood G, Junkins-Hopkins J, Olsen E, Sundram u, Pincus L, Rosen ST, Janyana D, Am Journal of Surgical Pathology, 1/1/2012
• Measuring Health-related Quality of Life in Leukemia: The Functional Assessment of Cancer Therapy-Leukemia (FACT-Leu) Questionnaire  
  Cella D, Jensen, SE, Webster MA, Honyan D, Jin-Shei L, Rosen ST, Tallman MS, Yount S, Value in Health, 1/1/2012
• Clinical end points and response criteria in mycosis fungoides and sezary syndrome: a consensus statement of the international society for cutaneous lymphomas, the Uni...  
  Olsen EA, Whittaker S, Kim YH, Duvic M, Prince HM, Lessin SR, Wood GS, Willemze R, Demierre MF, Pimpinelli N, Bernengo MG, Ortiz-Romero PL, Bagot M, Estrach T, Guitart..., J Clin Oncol, 1/20/2011
• Join now to see all

Books/Book Chapters

• Lymphoma 
  Chapter: T-cell non-Hodgkin lymphoma 
  Kirchner S, Nelson B, Rosen ST, Evens AEdition 2nd,2014
• Clinical Oncology 
  Chapter: Cutaneous T-Cell Lymphoma and Cutaneous B-Cell Lymphoma 
  Querfield, C, Rosen STEditors: Niederhuber, Armitage, Doroshow, Kastan, Tepper.2014
• Cancer Treatment and Research 
  Chapter: Infectious Complications in Cancer Patients 
  Valentina Stosor, Teresa R. Zembower, Rosen ST (Series Ed)Editors: Valentina Stosor, Teresa R. Zembower, Rosen ST (Series Ed).2014
• Current Understanding and treatment of Gliomas 
  Jeffrey Raizer, Andrew Parsa, Rosen ST (Series Ed)Editors: Jeffrey Raizer, Andrew Parsa, Rosen ST (Series Ed).Springer2014
• RNA and Cancer 
  Chapter: Clinical Perspective on Chemo-Resistance and the Role of RNA Processing 
  Page 235 - 245Krett NL, Ma S, Rosen STSpringer -Verlag Berlin Heidelberg Publishing, Berlin, Germany2013
• Cancer Treatment and Research 
  Chapter: RNA and Cance 
  Wu, J (editor), Rosen ST (Series Ed)Editors: Wu, J (editor), Rosen ST (Series Ed).Springer-Verlag, Berlin, Germany2013
• Cancer Treatment and Research 
  Chapter: Advances in Nutrition and Cancer 
  Zappia V, Panico S, Russo GL, Budillon A, Radione FD (ed), Rosen ST (Series Ed)Editors: Zappia V, Panico S, Russo GL, Budillon A, Radione FD (ed), Rosen ST (Series Ed).2013
• Cancer Treatment and Research 
  Chapter: Endocrine Neoplasia 
  Sturgeon C (ed), Rosen ST (Series Ed)Editors: Sturgeon C (ed), Rosen ST (Series Ed).Springer Publishing, New York, NY2010
• Cancer Treatment and Research 
  Chapter: Cancer Genetics 
  Pasche B (ed), Rosen ST (Series Ed)Editors: Pasche B (ed), Rosen ST (Series Ed).Springer Publishing, New York, NY2010
• Cancer Treatment and Research 
  Chapter: Cytopathology in Oncology 
  Nayar, R (editor), Rosen ST (Series Ed)Editors: Nayar, R (editor), Rosen ST (Series Ed).Springer Publishing, New York, NY2010
• Dr. Locouture's Skin Care Guide for People Living With Cancer 
  Chapter: Foreword (Editorial) 
  Mario E. Lacouture, MDHarborside Press2010
• Hematology: Basic Principles and Practice 
  Chapter: Cutaneous T-Cell Lymphomas. 
  Kuzel TM, Guitart J, Rosen STEdition 5th,2009
• Non-Hodgkin Lymphomas 
  Chapter: Primary Cutaneous B-Cell Lymphoma 
  Querfeld C, Guitart J, Rosen STEdition 2nd,2009
• Non-Hodgkin Lymphomas 
  Chapter: Primary Cutaneous CD30+ Lymphoproliferative Disorders 
  Querfeld C, Guitart J, Rosen STEdition 2nd,2009
• Cancer Treatment and Research 
  Chapter: Coagulation in Can 
  Green D, Kwaan HC (ed), Rosen ST (Series Ed)Editors: Green D, Kwaan HC (ed), Rosen ST (Series Ed).Springer Publishing, New York, NY2009
• Cancer Treatment and Research 
  Chapter: Skin Cancer after Organ Transplantation 
  Stockfleth E, Ulrich C, Euvrard S, Proby C, Bavinck JB, Geissler EK, Gjersvik P (ed.), Rosen ST (series ed)Editors: Stockfleth E, Ulrich C, Euvrard S, Proby C, Bavinck JB, Geissler EK, Gjersvik P (ed.), Rosen ST (series ed).Springer Publishing, New York, NY2009
• Cancer Treatment and Research 
  Chapter: Late Effects of Treatment for Brain Tumors 
  Goldman S, Turner CD (ed), Rosen ST (Series Ed)Editors: Goldman S, Turner CD (ed), Rosen ST (Series Ed).Springer Publishing, New York, NY2009
• Cancer Treatment and Research 
  Chapter: Adjuvant Therapy for Breast Cancer 
  Castiglione M, Piccart MJ (ed), Rosen ST (Series Ed)Editors: Castiglione M, Piccart MJ (ed), Rosen ST (Series Ed).Springer Publishing, New York, NY2009
• Cancer Treatment and Research 
  Chapter: Pediatric and Adolescent Osteosarcoma 
  Jaffe N, Bruland OS, Bielack S (ed), Rosen ST (Series Ed)Editors: Jaffe N, Bruland OS, Bielack S (ed), Rosen ST (Series Ed).Springer Publishing, New York, NY2009
• Cancer Treatment and Research 
  Chapter: Ovarian Cancer 
  Stack MS, Fishman DA (ed), Rosen ST (Series Ed)Editors: Stack MS, Fishman DA (ed), Rosen ST (Series Ed).Springer Publishing, New York, NYEdition 2nd,2009
• Cancer Treatment and Research 
  Chapter: Acute Myelogenous Leukemia: Genetics, Biology and Therapy 
  Nagarajan L (ed), Rosen ST (Series Ed)Editors: Nagarajan L (ed), Rosen ST (Series Ed).Springer Publishing, New York, NY2009
• Cancer Management: A Multidisciplinary Approach 
  Chapter: Non-Hodgkin lymphoma 
  Page 719 - 74Rosen ST, Winter JN, Gordon LI, Evens AM, Chiu BC-H, Tsang REdition 11th,2008
• A Guide for the community oncologist 
  Chapter: Cutaneous T-cell lymphomas: Mycosis fungoides and Sezary syndrome. 
  Querfeld C, Kuzel TM, Guitart J, Rosen STCMP MedicaEdition 2nd,2008
• Cancer Treatment and Research 
  Chapter: Rare Hematological Malignancies 
  Ansell SM (ed), Rosen ST (series ed)Editors: Ansell SM (ed), Rosen ST (series ed).Springer Publishing, New York, NY2008
• Cancer Treatment and Research 
  Chapter: Ethical Issues in Cancer Patient Care 
  Angelos P (ed), Rosen ST (series ed)Editors: Angelos P (ed), Rosen ST (series ed).Springer Publishing, New York, NYEdition 2nd,2008
• Join now to see all

Abstracts/Posters

• Preliminary Results from a Phase 2 Trial of Brentuximab Vedotin Plus Cyclophosphamide, Doxorubicin, Etoposide, and Prednisone (CHEP-BV) Followed By BV Consolidation in...
  Steven Rosen, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• FLT3-ITD Activates Cytoplasmic Drosha-Dependent Non-Canonical Mechanisms of Mir-155 Biogenesis in Acute Myeloid Leukemia
  Steven Rosen, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Preliminary Results from a Phase I Trial of Pembrolizumab Plus Vorinostat in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, a...
  Steven Rosen, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Phase 1 Results of Anti-PD-Ligand 1 (Durvalumab) & Lenalidomide in Patients with Cutaneous T Cell Lymphoma and Correlation with Programmed Death Ligand 1 Expression an...
  Steven Rosen, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Spred1 Insufficiency in the Hematopoietic and/or Vascular Compartments of the Bone Marrow (BM) Niche Promotes Aggressive Leukemogenesis in Chronic Myelogenous Leukemia...
  Steven Rosen, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• PET-Adapted Nivolumab or Nivolumab Plus ICE As First Salvage Therapy in Relapsed or Refractory Hodgkin Lymphoma
  Steven Rosen, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Outcome of Patients Treated With a Single-Fraction Dose of Radiation for Lymphomatoind Papulosis.
  Gentile MS, Thomas TO, Agrawal P, Guitart J, Rosen, ST, Kuzel T, Mittal BB, ASCO Annual Meeting, 1/1/2013
• Bisphosphonates and Esophageal Cancer: A RADAR report.
  Edwards, BJ, Nardone B, Raisch DW, Mckoy JM, Belknap SM, Holbrook JS, Garg V, Shen X, Godinez-Puig V, Trifillio SM, Emmanuel R, West DP, Rosen ST, ASCO Annual Meeting, 1/1/2013
• Phase II Neoadjuvant Trial with Carboplatin and Eribulin Mesylate In Patients with Triple-Negative Breast Cancer.
  Barnato SE, Jeruss JS, Bethke KP, Hansen NM, Khan SA, Von Roenn JH, Rosen ST, Gradishar WJ, Siziopikou KP, MeserveyC, Kaklamani VG, ASCO Annual Meeting, 1/1/2013
• Phase I trial of Pegylated Liposomal Doxorubicin and Lapatinib in the Treatment of Metastatic Breast Cancer (MBC: Final Results.
  Cianfrocca ME, Kaklamani VG, Rosen ST, VonRoenn JH, Rademaker A, Smith DA, Rubin SD, Meservey C, Uthe R, Gradishar WJ, ASCO Annual Meeting, 1/1/2013
• Belknap SM, Godinez-Puig V, Brannigan RE, Lin SM, Cashy J, Chowdhary R, Postelnick MJ, Fotis, MA, Irwig M, Khan SA, Gradishar WJ, Garg V, Shen X, Raisch DW, Nardone B,..., ASCO Annual Meeting, Chicago, IL, 1/1/2013
• Phase II Neoadjuvant Trial with Carboplatin and Eribulin Mesylate in Patients with Triple Negative Breast Cancer.
  Giordano SB, Rao S, Siziopikou KP, Jovanovic B, Hamden R, Jeruss JS, Shea LD, Bethke KP, Hansen NM, Khan S, Billimoria K, Von Roenn JH, Rosen ST, Hoskins K, Jain S, Me..., San Antonio, TX, 1/1/2013
• A Multicenter Phase II Study of Bortezomib (VELCADE®) Combined With Rituximab for Untreated High Tumor Burden (HTB) Indolent Non-Hodgkin Lymphoma (NHL): Long-Term Foll...
  Evans AM, Smith MR, Lossos IS, Helenowski I, Millenson M, Winter JN, Rosen ST, Gordon L, 55th ASH Annual Meeting and Exposition, New Orleans, LA, 1/1/2013
• Targeting Glycolysis and Compensary Mitochondrial Metabolism In An In vivo Xenograft Model of Multiple Myeloma With FDA Approved Ritonavir and Metformin.
  Dalva-Aydemir S, Adekola KUA, Koblinski J, Raje N, Rosen ST, Shanmugam M, 55th ASH Annual Meeting and Exposition, New Orleans, LA, 1/1/2013
• Synergy of Small-Molecule Inhibitors in Cutaneous T-Cell Lymphoma Cells: A Discovery Tool To Define New Therapeutic Targets In T-Cell Receptor (TCR) Signaling Pathways.
  Bliss-Moreau M, Coarfa C, Xiao W, Gunaratne P, Krett NL, Rosen ST, 55th ASH Annual Meeting and Exposition, New Orleans, LA, 1/1/2013
• Analysis of Peripheral T-Cell Lymphoma (PTCL) Subtype By Race and Geography Using The Comprehensive Oncology Measures For Peripheral T-Cell Lymphoma Treatment (COMPLET...
  Carson, KR, Foss FM, Pinter-Brown L, Horwitz SM, Rosen, ST, Pro B, Federico M, Gisselbrecht C, His ED, 55th ASH Annual Meeting and Exposition, New Orleans, LA, 1/1/2013
• A Phase I Trial of Pegylated Liposomal Doxorubicin (Doxil™), and Lapatinib in the Treatment of Metastatic Breast Cancer (MBC): Final Results.
  Cianfrocca M, Kaklamani V, Rosen ST, von Roenn J, Rademaker AW, Rubin SD, Friedman RA, Meservey C, Uthe R, Gradishar WJ, ASCO Annual Meeting, Chicago, IL, 1/1/2012
• Optimal Prophylaxis for VTE in Multiple Myeloma Patients on LEN and THAL: The search continues.
  McKoy JM, Liebling DB, Rademaker A, Weitner S, Edwards BJ, Rosen ST, Zakarija A, Tulas KM, Belknap S, West DW, ASCO Annual Meeting, Chicago, IL, 1/1/2012
• Outcome of Patients Treated with Single-Fraction Dose of Radiation for Lymphomatoid Papulosis.
  Gentile MS, Thomas TO, Agrawal P, Guitart J, Rosen ST, Kuzel T, Mittal BB, ASCO Annual Meeting, Chicago, IL, 1/1/2012
• Using the Bioconductor GeneAnswers Package to Interpret Gene Lists
  Feng G, Shaw P, Rosen ST, Lin SM, Kibbe WA, Methods Mol Biology, 1/1/2012
• Biomarker Quality Assurance (QA) Findings from the Comprehensive Oncology Measures for Peripheral T-Cell Lymphoma Treatment (COMPLETE) Registry.
  His ED, Gruver AM, Foss FM, Carson KR, Pinter-Brown LC, Horwitz SM, Rosen ST, Pro B, Federico M, Gisselbrecht C, Zucca E, American Society of Hematology, 1/1/2012
• Comprehensive Oncology Measures for Peripheral T-Cell Lymphoma Treatment (COMPLETE): First Detailed Report of Primary Treatment.
  Foss FM, Carson KR, Pinter-Brown LC, Horwitz SM, Rosen ST, Federico M, Gisselbrecht C, His ED, Zucca E, American Society of Hematology, 1/1/2012
• Survival of newly Diagnoses T-Cell Lymphoma (TCL) in the Modern Era: Investigation of Prognostic Factors with Critical Examination of Therapy in a Multicenter US Cohort.
  Evens A, Chadi N, Winer E, Castillo J, Rosen ST, Goy A, Flowers C, Abramson J, Smith SM, Feldman T, American Society of Hematology, 1/1/2012
• Allogeneic HSCT in patients with cutaneous T cell lymphoma: The Robert H. Lurie Comprehensive Cancer Center experience.
  Querfeld C, Guitart J, Rosen ST, Kuzel TM, Rademaker F, Mehta J, 5th International Symposium On The Biology and Immunology of Cutaneous Lymphomas, Berlin, Germany, 1/1/2011
• Aberrant plasma membrane localization of GLUT4 sustains the glucolytic phenotype in multiple myeloma.
  McBrayer, SK, Cheng , JC, Krett, NL, Rosen ST and Shanmugam M, Proceedings, 102st Annual Meeting of the American Association for Cancer Research, 1/1/2011
• Join now to see all

Lectures

• Cancer Informatics for Cancer Centers 
  San Francisco Bay Area - 1/20/2014
• Modern Biologic Therapeutics for Cancer 
  San Francisco Bay Area - 1/20/2014
• Overview of Modern Oncologic Therapies 
  Las Vegas, NV - 1/6/2014
• WHO Classification of Haematopoietic and Lymphoid Neoplasms 
  1/1/2014
• Predictive & Prognostic Tools in Individualizing Therapy Selection in NHL and CL 
  Washington, DC - 1/1/2013
• The Chronology of a Career in Translational Research 
  Chicago, IL - 1/1/2013
• T Cell Lymphomas 
  Chicago, IL, 1989, 2013 - 1/1/2013
• Cutaneous Lymphomas 
  Multiple Locations, 1999, 2002, 2003, 2013 - 1/1/2013
• T-Cell and NK-Cell Lymphoproliferative Disorders 
  Multiple Locations, 2011, 2012 - 1/1/2012
• Biologic Therapies in CTCL and PTCL 
  Hong Kong, China - 1/1/2012
• T Cell and NK Cell Lymphoproliferative Disorders 
  Hoag Hospital, VA - 1/1/2012
• New Agents in CTCL: How Should They Be Integrated Into Overall Management 
  Chicago IL - 1/1/2012
• Targeted Therapies in Oncology 
  Northbrook Cancer Wellness Center, Northbrook, IL - 1/1/2012
• Evaluation of a Phase II Multicenter Trial of Lenalidomide (NU-04H5) in Patients With Relapsed CTCL 
  Bologna, Italy - 1/1/2012
• Overview of Cancer 
  Chicago, IL - 1/1/2011
• CD-30 positive Systemic Anaplastic Large Cell Lymphomas 
  San Francisco, CA - 1/1/2011
• Cutaneous T-Cell Lymphoma: Overview and Case Study 
  Tampa, FL - 1/1/2011
• Clinical Challenges for Nanotechnology Applications in Oncology 
  Dartmouth College, Hanover, NH, 2011; Chicago, IL, 2011 - 1/1/2011
• Hematologic Malignancies 
  Miami, FL - 1/1/2010
• Enzastaurin Treatment of Cutaneous T-Cell Lymphoma 
  Maui, HI - 1/1/2010
• Peripheral T-Cell Lymphoma 
  Hackensack, NJ - 1/1/2010
• Overview of Chronic Lymphocytic Leukemia and Rituxan in Combination with FC for Previously Untreated and Previously Treated CD-20 positive CLL 
  Highland Park, IL, 2010; Chicago, IL, 2010 - 1/1/2010
• Focusing on T-Cell Lymphomas: New Approaches to Diagnosis and Treatment. 
  SUNY Upstate Medical University, Syracuse, NY - 1/1/2010
• T-Cell Lymphomas: New Approaches to Diagnosis and Treatment. 
  Waukegan, IL - 1/1/2010
• Odds and Ends: CLL, CTCL and Myeloma. 
  Houston, TX - 1/1/2010
• Join now to see all

Other

• Clinical Endpoints and Response Criteria in Mycosis Fungoides and Sezary Syndrome: a Consensus Statement of the International Society for Cutaneous Lymphomas (ISCL), t... 
  Olsen EA, Whittaker S, Kim Y, Duvic M, Prince M, Lessin S, Wood G, Willemze R, Demierre M, Pimpinelli N, Bernengo M, Romero P, Bagot M, Estrach T, guitar J, Knobler R,...
  1/1/2010
• Clinical Vignettes in Cutaneous T-Cell Lymphoma: Practical Applications for Emerging Data on Mycosis Fungoides/Sezary Syndrome. 
  Rosen ST, Grand Rounds in Hematology, Volume 2 Issue 1
  1/1/2009
• Optimizing Management Strategies for Patients with Hematologic Malignancies: A Case-Based Approach. 
  Karp JE, Rosen ST, Pratz KW, Friedberg JW, Franfurt O, Blamble DA, Moran M, McMahon Group
  1/1/2008
• ASCO 2008 Desk Reference: Practice-Changing Implications Today Compelling Data For Tomorrow 
  Rosen ST (guest ed.)
  Chicago, IL - 1/1/2008
• Clinical Roundtable Monograph: Recent Advances in the Treatment of Non-Hodgkin Lymphoma. 
  Cheson BD (moderator), Friedberg J (discussant), Rosen ST (discussant)
  1/1/2008
• The Hematology Circle, Rebalancing Molecular Profiles in Hematologic Malignancies: New Technologies for Targeting Silenced and Overexpressed Genes. 
  Rosen ST (moderator)
  1/1/2008
• Advancing Treatment Paradigms in Hematologic Malignancies: Highlights from the 13th EHA Congress. 
  Erba HP, Rosen ST, (Editors), CME/CE Newsletter
  1/1/2008
• Conversations with Oncology Research Leaders. 
  Rosen ST, Smith MR, Kahl BS, Non-Hodgkin's Lymphoma Update, Research To Practice
  1/1/2005
• Recent Developments and Future Directions in the Treatment of Multiple Myeloma. 
  Rosen ST (Chair)
  1/1/2002
• Maximizing Radiotherapy for Improved Patient Outcome. 
  Rosen ST (Editor)
  1/1/1998
• Join now to see all